FIGURE 7.
Serum EV-derived miRNA-105-5p of ESCC patients accelerates cell processes. (A–C) CCK-8 assay (A), wound healing assay (×40), /(B) and Transwell invasion assay (×100) (C) were performed to evaluate ESCC cell proliferation, migration, and invasion after ESCC cells were co-cultured with PBS or serum EVs of ESCC patients, respectively; *p < 0.05.